Pfizer to buy Anacor in deal valued at $5.2 billion

Pfizer has agreed to acquire Anacor Pharmaceuticals in a deal valued at $5.2 billion. Bloomberg's Jeff McCracken has the details on the Pfizer deal and looks at Gannett's pursuit of Tribune Publishing.